Treatment of Ovarian Cancer in Clear Cell Carcinoma of the Ovary
Clear cell carcinoma of the ovary is a distinct histological subtype that carries specific clinical characteristics and requires a tailored treatment approach separate from the more common epithelial subtypes.
Clinical scenario: This protocol addresses ovarian cancer arising as clear cell carcinoma — a histotype that directly shapes treatment selection at every stage of management, from initial therapy through recurrence.
Treatment approach — overview
Management of clear cell carcinoma is guided by platinum sensitivity, disease stage, and molecular profile. Depending on the clinical situation, approaches may involve immunotherapy combinations or alternative chemotherapy regimens; for patients with specific genetic features, maintenance therapy is an additional consideration. The complete structured protocol details the full decision pathway.
References
- Clear cell carcinoma of the ovary
- For clear-cell carcinoma
- Ipilimumab + Nivolumab
- Irinotecan/Cisplatin (for clear cell carcinoma)